Contents
A healthy pregnancy begins with early prenatal care, informed lifestyle choices, and appropriate monitoring throughout each trimester. Nutrition, physical activity, vaccines, emotional health, medication safety, and regular visits with an obstetric healthcare professional all play important roles.
Laboratory testing adds objective information that symptoms and physical examinations cannot always provide. Blood and urine tests may help identify anemia, blood-type incompatibility, certain infections, glucose abnormalities, immunity gaps, and other health concerns that can affect pregnancy.
Ulta Lab Tests pregnancy and fertility testing provides access to many pregnancy-related and general wellness tests that patients can use to prepare for informed conversations with their healthcare providers. Direct-access laboratory testing does not replace prenatal care, ultrasound, fetal monitoring, genetic counseling, or evaluation by a qualified obstetric clinician.
A healthy pregnancy is one in which the pregnant patient and developing fetus receive appropriate medical care, nutrition, monitoring, and support from conception through delivery and the postpartum period.
It does not mean that every day will feel comfortable or that every test will be perfectly within range. Nausea, fatigue, breast tenderness, urinary frequency, mild swelling, and other physical changes may occur during an uncomplicated pregnancy. At the same time, some significant conditions can develop with mild symptoms or no obvious symptoms.
Early and ongoing prenatal care helps clinicians review medical history, medications, family history, previous pregnancies, blood pressure, weight, fetal development, and laboratory findings. The timing and format of prenatal visits may be individualized according to health history, pregnancy risk, symptoms, and patient needs.
Pregnancy affects nearly every major body system. Blood volume increases, hormone concentrations change, kidney filtration rises, insulin sensitivity shifts, and nutritional requirements evolve. These normal changes can alter laboratory values and may also reveal previously unrecognized health concerns.
A healthy pregnancy plan can help address or monitor:
Awareness cannot guarantee that complications will be avoided. It can help patients recognize concerns promptly and have better-informed conversations with their obstetric care team.
Contact a qualified prenatal healthcare professional as soon as pregnancy is suspected or confirmed. The first visit commonly includes a review of medical and pregnancy history, medications, family history, blood pressure, weight, routine laboratory testing, and plans for ultrasound or genetic screening.
Folic acid is a form of vitamin B9 needed for new-cell formation. It is especially important before conception and during early pregnancy because the neural tube, which becomes the brain and spinal cord, develops very early.
A prenatal vitamin may also provide iron, iodine, vitamin D, vitamin B12, and other nutrients. More is not always better. Excessive supplementation may be harmful, so doses should be reviewed with a prenatal healthcare professional.
Focus on a varied diet that includes vegetables, fruits, whole grains, beans, eggs, lean proteins, pasteurized dairy products or appropriate alternatives, nuts, seeds, low-mercury fish, and adequate fluids.
Pregnant patients should avoid unpasteurized products, raw or undercooked meat and eggs, raw seafood, and other foods associated with increased foodborne-illness risk. Current pregnancy-specific guidance should be followed when choosing fish because mercury exposure varies by species.
No known amount or timing of alcohol use is considered safe during pregnancy. Smoking, vaping, cannabis, and nonmedical drug use should also be discussed confidentially with a qualified healthcare professional. Patients who used a substance before recognizing a pregnancy should seek appropriate prenatal care and discuss the exposure honestly with their provider.
Do not start, stop, or change a prescription medicine because of pregnancy without speaking with the prescribing clinician. Untreated health conditions may also carry risks, and some medications remain important during pregnancy.
Review prescription medicines, over-the-counter products, herbal remedies, athletic supplements, vitamins, minerals, skin-care products with active medications, and sleep aids with a physician, nurse practitioner, midwife, or pharmacist.
For many uncomplicated pregnancies, moderate physical activity may support cardiovascular fitness, strength, sleep, mood, and healthy pregnancy weight gain. Walking, swimming, modified strength exercises, and prenatal exercise programs are common options.
Stop exercising and seek guidance for bleeding, dizziness, chest pain, painful contractions, fluid leakage, or significant shortness of breath.
Vaccination recommendations may depend on the season, gestational week, medical history, and previous vaccines. Discuss influenza, Tdap, COVID-19, and maternal RSV vaccination with your prenatal clinician. Live vaccines, including MMR, are generally not given during pregnancy, so immunity should ideally be reviewed before conception.
Hormonal changes, physical discomfort, uncertainty, and life stress can affect sleep and mental health. Tell your prenatal provider about persistent sadness, panic, intrusive thoughts, severe anxiety, inability to function, or loss of interest in usual activities. Thoughts of harming yourself or the baby require immediate help.
Prenatal tests may evaluate maternal health, fetal development, inherited risks, and infections. Some are routinely offered, while others depend on age, medical history, symptoms, exposures, or personal preferences.
Screening tests estimate risk and do not necessarily diagnose a condition. Cell-free DNA screening, for example, is not the same as a diagnostic procedure such as chorionic villus sampling or amniocentesis.
Seek immediate medical care for a severe or worsening headache, fainting, persistent dizziness, vision changes, fever, significant swelling of the face or hands, chest pain, trouble breathing, severe vomiting, severe abdominal pain, vaginal bleeding, fluid leakage, reduced fetal movement, or thoughts of harming yourself or the baby.
These symptoms should not be evaluated through self-ordered lab testing alone. Contact your prenatal care team, emergency services, or an emergency department as appropriate.
| Symptom or Risk Factor | What It May Suggest | Related Tests or Evaluations |
|---|---|---|
| Persistent fatigue, weakness, pallor, or shortness of breath | Anemia, iron deficiency, thyroid dysfunction, infection, or another condition | Complete Blood Count with Differential and Platelets, Ferritin Test, Ferritin, Iron and Total Iron Binding Capacity Panel, and TSH and Free T4 Test when appropriate |
| Burning urination, urinary frequency, back pain, or no urinary symptoms | Urinary tract infection or asymptomatic bacteriuria | Urinalysis Complete Test and Urine Culture Test |
| Excessive thirst, frequent urination, previous gestational diabetes, or metabolic risk | Elevated glucose or increased gestational diabetes risk | Glucose Test, Hemoglobin A1c and Glucose Panel, or a provider-directed Gestational Glucose Tolerance Test, 3 Specimens, 75g |
| Palpitations, unusual heat or cold intolerance, tremor, or marked fatigue | Possible thyroid dysfunction or another medical concern | TSH and Free T4 Test, with additional thyroid testing when clinically indicated |
| High blood pressure, severe headache, vision changes, or sudden swelling | Possible hypertensive disorder requiring prompt assessment | Blood pressure evaluation, Complete Blood Count with Platelets, Comprehensive Metabolic Panel Test, and Protein Total Random Urine Test with Creatinine under medical supervision |
| Fever, rash, swollen glands, or a significant infectious exposure | An infection requiring clinician-directed evaluation | Targeted infectious-disease testing based on symptoms and exposure |
| Vaginal bleeding, severe pelvic pain, shoulder pain, or fainting | A pregnancy emergency, including possible pregnancy loss or ectopic pregnancy | Immediate clinical assessment, ultrasound, and clinician-directed hCG Total Quantitative Test or other testing |
| Reduced fetal movement or fluid leakage | Potential fetal or obstetric concern | Immediate obstetric evaluation rather than a self-ordered blood test |
Laboratory testing may identify measurable changes that are not obvious from symptoms alone. It can provide information about anemia, iron depletion, glucose abnormalities, thyroid dysfunction, infection, immunity, blood-type incompatibility, and kidney or liver markers.
Laboratory testing also has important limits:
Trends may be more informative than a single value. A changing hemoglobin level, platelet count, urine protein result, or liver enzyme measurement can have different significance depending on gestational age and the overall clinical situation.
| Lab Test or Biomarker | What It Measures | Why It May Be Relevant | General Meaning and Limitations |
|---|---|---|---|
| Complete Blood Count with Differential and Platelets | Red cells, hemoglobin, hematocrit, white cells, and platelets | Screens for anemia and provides information about infection patterns and platelet count | Pregnancy-related blood-volume expansion can lower hemoglobin and hematocrit. Abnormal results require clinical interpretation. |
| Ferritin Test | Stored iron | Helps evaluate possible iron depletion or iron-deficiency anemia | Low ferritin commonly supports iron deficiency. Ferritin may rise with inflammation and should not always be interpreted alone. |
| Ferritin, Iron and Total Iron Binding Capacity Panel | Ferritin, circulating iron, iron-binding capacity, and iron saturation | Adds context when anemia or iron depletion is suspected | Results can vary with supplements, meals, inflammation, and timing. |
| ABO Group and Rh Type Test | ABO blood group and Rh D status | Identifies patients who may need Rh-related pregnancy management | Rh-negative patients require clinician-directed antibody monitoring and pregnancy care. |
| Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing | Unexpected red blood cell antibodies | Helps identify antibodies that may be relevant to maternal-fetal blood compatibility | A positive result requires antibody identification and obstetric follow-up. |
| Rubella Titer Test | Rubella antibodies associated with immunity | Helps determine whether a patient appears immune to rubella | It does not determine whether fetal infection is present. Live rubella vaccine is generally not given during pregnancy. |
| Varicella-Zoster Virus Antibody Immunity Screen | Antibodies associated with chickenpox immunity | Helps assess susceptibility to varicella | Results should be interpreted with vaccination and disease history. |
| Hepatitis B Surface Antigen Test with Reflex to Confirmation | Hepatitis B surface antigen | Supports maternal and newborn care planning when current hepatitis B infection is present | Additional hepatitis testing may be needed after a reactive result. |
| Hepatitis C Antibody Test with Reflex to RNA Quantitative PCR | Hepatitis C antibodies with RNA confirmation when applicable | Identifies possible current or past hepatitis C exposure | Antibody positivity alone does not establish current infection. |
| HIV-1/2 Antigen and Antibodies, Fourth Generation | HIV antigen and antibodies | Early identification supports timely medical care during pregnancy | Reactive screening results require confirmatory testing and medical follow-up. |
| RPR Test with Reflex to Titer and Confirmatory Testing | Antibodies used in syphilis screening | Syphilis screening is an important part of prenatal care | False-positive screening results may occur, so confirmation is necessary. |
| Chlamydia and Gonorrhea Test | Genetic material from chlamydia and gonorrhea bacteria | May be recommended according to age, symptoms, exposure, and infection risk | Collection site and timing matter. Treatment and retesting are clinician-directed. |
| Urine Culture Test | Bacterial growth from urine | Screens for asymptomatic bacteriuria and evaluates possible urinary tract infection | Contamination may occur. Symptoms or a positive culture require clinical follow-up. |
| TSH and Free T4 Test | Thyroid-stimulating hormone and free thyroxine | May be useful with thyroid disease, symptoms, autoimmune history, infertility, or other risk factors | Pregnancy- and trimester-specific interpretation is important. |
| Gestational Glucose Tolerance Test, 3 Specimens, 75g | Fasting, one-hour, and two-hour glucose response | Used in pregnancy-specific evaluation of gestational diabetes | Testing protocol and interpretation should be coordinated with the prenatal provider. |
| Hemoglobin A1c and Glucose Panel | Current glucose and approximate average glucose over recent months | May help assess preexisting glucose concerns before pregnancy or early in selected pregnancies | It does not replace standard pregnancy-specific gestational diabetes screening. |
| Vitamin B12 and Folate Panel Test | Vitamin B12 and folate levels | May be appropriate with anemia, a restricted diet, malabsorption, or nutritional risk | Serum levels can be influenced by supplements and do not independently assess fetal health. |
| Vitamin D 25-Hydroxy Total Test | The main circulating marker used to assess vitamin D status | May be considered for patients with deficiency risk or a history of low vitamin D | Universal testing is not needed for every pregnancy, and supplementation should be clinician-directed. |
| hCG Total Quantitative Test | The concentration of human chorionic gonadotropin | May help evaluate specific early-pregnancy questions when ordered serially | A single result generally cannot determine pregnancy viability or location. Ultrasound and trends may be needed. |
| Comprehensive Metabolic Panel Test | Glucose, electrolytes, kidney markers, liver markers, and proteins | May be used when medical history or symptoms raise concerns about metabolic, kidney, liver, or hypertensive complications | Not every pregnant patient needs repeated comprehensive metabolic testing. |
| Protein Total Random Urine Test with Creatinine | Urine protein relative to urine creatinine | May be used during the evaluation of hypertension or suspected preeclampsia | Should be interpreted with blood pressure, symptoms, gestational age, and other clinical findings. |
A clinician-directed early prenatal evaluation commonly includes:
Some patients may also discuss the Obstetric Panel or ULTA Comprehensive Obstetric - Prenatal Panel with their healthcare provider. Panel contents should be reviewed carefully to confirm that the selected tests match the clinician’s prenatal plan.
These tests may be considered when symptoms, history, diet, medication use, or prior results support testing:
Depending on gestational age and individual risk, the prenatal care team may recommend cell-free DNA or other chromosome screening, maternal serum screening, ultrasound, anatomy evaluation, a Gestational Glucose Tolerance Test, 3 Specimens, 75g, repeat blood counts or iron studies, repeat antibody testing, group B strep screening, or repeat infection testing.
Some pregnancy tests require precise timing, special specimen collection, genetic counseling, ultrasound correlation, or immediate clinical follow-up. These tests should be coordinated with the prenatal care team.
Patients with hypertension, diabetes, thyroid disease, kidney disease, autoimmune disease, severe anemia, multiple pregnancy, or previous pregnancy complications may need additional monitoring. The schedule should be determined by the obstetric care team rather than a generalized self-directed testing plan.
A reference range represents values found in a defined laboratory population. It is not a rigid boundary between health and disease.
Pregnancy can change hemoglobin, hematocrit, white blood cell count, creatinine, albumin, total protein, alkaline phosphatase, thyroid measurements, glucose metabolism, and iron markers. Some tests require trimester-specific ranges.
There is no single universal set of optimal pregnancy ranges for every patient. Interpretation should rely on validated pregnancy-specific ranges, the testing laboratory’s methodology, gestational age, clinical guidelines, and the patient’s complete health picture.
Results may be affected by gestational age, hydration, meals, supplements, medications, recent illness, collection time, laboratory method, multiple pregnancy, and preexisting health conditions. Repeat testing may be needed to confirm an unexpected result or evaluate a trend.
Ulta Lab Tests offers access to many blood and urine tests that may support preconception planning, nutritional assessment, and informed discussions about maternal health.
Pregnancy-specific testing should remain coordinated with prenatal care. Self-ordered testing cannot replace ultrasound, fetal monitoring, blood pressure evaluation, genetic counseling, or urgent medical assessment.
Early prenatal testing commonly includes a Complete Blood Count with Differential and Platelets, ABO Group and Rh Type Test, Antibody Screen, Rubella Titer Test, hepatitis B, hepatitis C, HIV, and syphilis screening. A Urine Culture Test and risk-based Chlamydia and Gonorrhea Test may also be recommended.
No single blood test can confirm that every aspect of a pregnancy is healthy. Blood tests provide information about maternal blood counts, infections, glucose, blood type, immunity, hormones, and nutritional status. Ultrasound, blood pressure monitoring, fetal growth assessment, physical examination, and other prenatal evaluations are also necessary.
Gestational diabetes screening is commonly performed during the second trimester, often between 24 and 28 weeks. Earlier glucose testing may be considered for patients with risk factors for previously unrecognized diabetes. A Gestational Glucose Tolerance Test, 3 Specimens, 75g should be selected and interpreted with the prenatal healthcare provider.
The ABO Group and Rh Type Test identifies a patient’s ABO blood group and Rh status. An Rh-negative patient carrying an Rh-positive fetus may develop antibodies against fetal red blood cells. An Antibody Screen helps the prenatal team determine whether relevant antibodies are present.
Not necessarily. A TSH and Free T4 Test may be especially relevant for patients with known thyroid disease, thyroid antibodies, symptoms, infertility history, autoimmune disease, goiter, medication exposure, or other risk factors. Pregnancy changes thyroid physiology, so results require pregnancy-specific interpretation.
Screening estimates the probability that a fetus may have a condition. Cell-free DNA, serum screening, and ultrasound markers are examples. Diagnostic procedures, such as chorionic villus sampling or amniocentesis, directly evaluate fetal genetic material. A positive screening result should not be treated as a diagnosis and usually requires counseling and confirmatory evaluation.
Carrier screening looks for gene variants associated with inherited conditions. It may be offered before conception or during pregnancy. A positive carrier result does not mean that the patient has the condition, but it may lead to partner testing, genetic counseling, and a discussion of reproductive options.
Group B strep screening is generally performed late in pregnancy with a vaginal and rectal swab. Colonization may change over time, so testing is completed close to delivery. A positive result helps the delivery team plan appropriate measures to reduce newborn infection risk.
Many general blood and urine tests can be ordered directly through Ulta Lab Tests Prenatal Health where available. Prenatal care should still be supervised by a qualified obstetric professional. Tests involving precise gestational timing, genetic screening, glucose challenges, special swab collection, suspected complications, or urgent symptoms should be coordinated with the prenatal care team.
Do not begin high-dose iron based only on one result without discussing it with your healthcare provider. A Ferritin Test, hemoglobin, iron saturation, diet, inflammation, symptoms, and pregnancy stage may all affect interpretation. Excess iron can cause side effects and may not address other causes of anemia.
Repeat testing depends on the biomarker and clinical situation. Some infection and immunity tests may be completed once, while blood counts, iron studies, glucose testing, antibody screening, or metabolic markers may be repeated. Patients with thyroid disease, diabetes, hypertension, anemia, or other conditions may require more frequent monitoring.
Seek urgent care for a severe headache, fainting, vision changes, chest pain, difficulty breathing, fever, heavy bleeding, severe abdominal pain, fluid leakage, significant swelling of the face or hands, reduced fetal movement, or thoughts of harming yourself or the baby. Do not wait for routine laboratory results when these symptoms occur.
A healthy pregnancy is supported by early prenatal care, balanced nutrition, folic acid, appropriate physical activity, medication review, recommended vaccines, emotional-health support, avoidance of harmful substances, and timely testing.
Pregnancy blood tests can provide valuable information about anemia, iron status, blood type, Rh factor, immunity, infections, thyroid function, glucose regulation, and other maternal health factors. They cannot replace ultrasound, blood pressure monitoring, fetal assessment, or professional prenatal care.
Explore prenatal health tests from Ulta Lab Tests and review every pregnancy-related result with a qualified healthcare provider.
A healthy pregnancy is supported by early prenatal care, adequate nutrition, recommended folic acid, safe physical activity, vaccine and medication review, avoidance of harmful substances, and appropriate pregnancy testing. Blood and urine tests may identify maternal health factors that affect pregnancy, but they do not replace obstetric care, ultrasound, or fetal monitoring.
Related lab tests: Complete Blood Count with Differential and Platelets, Ferritin Test, Ferritin, Iron and Total Iron Binding Capacity Panel, ABO Group and Rh Type Test, Antibody Screen, Rubella Titer Test, Varicella Immunity Screen, Hepatitis B Surface Antigen Test, Hepatitis C Antibody Test, HIV Testing, Syphilis RPR Test, Chlamydia and Gonorrhea Test, Urine Culture Test, TSH and Free T4 Test, Gestational Glucose Tolerance Test, Vitamin B12 and Folate Panel Test, Vitamin D 25-Hydroxy Total Test, hCG Total Quantitative Test, Comprehensive Metabolic Panel Test, and Protein Total Random Urine Test with Creatinine.
Ulta Lab Tests helps patients access many blood and urine tests directly online, view transparent pricing, and receive results securely for review with their healthcare providers. Laboratory testing is informational and should be interpreted with a qualified prenatal healthcare professional.
Ulta’s Obstetric Panel includes core prenatal components such as CBC, blood type and Rh factor, antibody screening, syphilis, hepatitis B, and rubella immunity testing.
Ulta’s anemia section identifies CBC, ferritin, iron/TIBC, vitamin B12, and folate as key laboratory categories for evaluating blood-cell and nutrient status.
These official Ulta pages cover maternal blood typing and unexpected red-cell antibody screening.
Ulta’s rubella and varicella pages provide testing options for evaluating detectable antibodies associated with prior infection or vaccination.
The linked Ulta pages include hepatitis B surface antigen, hepatitis C screening, fourth-generation HIV options, syphilis testing, and chlamydia and gonorrhea testing.
These Ulta pages provide direct links for urinalysis and urine-culture testing discussed in the article.
Ulta provides separate TSH, free T4, combined TSH/free T4, and pregnancy-specific TSH product pages.
The gestational glucose page covers a pregnancy-specific three-specimen glucose tolerance test, while the glucose and A1c pages provide general blood-sugar testing options.
The linked products measure vitamin B12, folate, and 25-hydroxy vitamin D.
The qualitative test reports whether hCG is detected, while the quantitative test reports a measured concentration.
Ulta’s CMP page includes metabolic, kidney, liver, glucose, protein, and electrolyte markers, while the random urine test measures protein relative to creatinine.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
